Abliva AB Financials
| ABLI Stock | SEK 0.44 0.01 2.33% |
Abliva |
Understanding current and past Abliva AB Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Abliva AB's financial statements are interrelated, with each one affecting the others. For example, an increase in Abliva AB's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Abliva AB's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Abliva AB. Check Abliva AB's Beneish M Score to see the likelihood of Abliva AB's management manipulating its earnings.
Abliva AB Stock Summary
Abliva AB competes with Cantargia, Mendus AB, and Oncopeptides. Abliva AB , a pharmaceutical company, engages in the research and development of mitochondrial medicine. Abliva AB was incorporated in 2000 and is headquartered in Lund, Sweden. Abliva AB is traded on Stockholm Stock Exchange in Sweden.| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0002575340 |
| Business Address | Medicon Village, Lund, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | abliva.com |
| Phone | 46 4 62 75 62 20 |
| Currency | SEK - Swedish Kronor |
You should never invest in Abliva AB without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Abliva Stock, because this is throwing your money away. Analyzing the key information contained in Abliva AB's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Abliva AB Key Financial Ratios
Abliva AB's financial ratios allow both analysts and investors to convert raw data from Abliva AB's financial statements into concise, actionable information that can be used to evaluate the performance of Abliva AB over time and compare it to other companies across industries.| Return On Equity | -0.8 | |||
| Return On Asset | -0.41 | |||
| Target Price | 1.0 | |||
| Beta | 1.17 |
Abliva Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Abliva AB's current stock value. Our valuation model uses many indicators to compare Abliva AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Abliva AB competition to find correlations between indicators driving Abliva AB's intrinsic value. More Info.Abliva AB is rated fifth in return on equity category among its peers. It also is rated fifth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Abliva AB's earnings, one of the primary drivers of an investment's value.Abliva AB Systematic Risk
Abliva AB's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Abliva AB volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was five with a total number of output elements of fifty-six. The Beta measures systematic risk based on how returns on Abliva AB correlated with the market. If Beta is less than 0 Abliva AB generally moves in the opposite direction as compared to the market. If Abliva AB Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Abliva AB is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Abliva AB is generally in the same direction as the market. If Beta > 1 Abliva AB moves generally in the same direction as, but more than the movement of the benchmark.
Abliva AB January 28, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Abliva AB help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Abliva AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of Abliva AB based on widely used predictive technical indicators. In general, we focus on analyzing Abliva Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Abliva AB's daily price indicators and compare them against related drivers.
| Downside Deviation | 6.27 | |||
| Information Ratio | 0.1161 | |||
| Maximum Drawdown | 202.33 | |||
| Value At Risk | (6.67) | |||
| Potential Upside | 7.14 |
Additional Tools for Abliva Stock Analysis
When running Abliva AB's price analysis, check to measure Abliva AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abliva AB is operating at the current time. Most of Abliva AB's value examination focuses on studying past and present price action to predict the probability of Abliva AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abliva AB's price. Additionally, you may evaluate how the addition of Abliva AB to your portfolios can decrease your overall portfolio volatility.